Investors
Key press releases
Key upcoming events
Key corporate presentation
Cellectis is listed on the Nasdaq Global Market (ticker: CLLS) and on the Euronext Growth Paris (ticker: ALCLS).
Cellectis ADS (Nasdaq)
Ticker: CLLS
$1.6100
+0.0300 (1.8987%)
- Prev. close
- 1.5800
- Volume
- 65,036
- High
- 1.6500
- Capitalization
- 116.071M
Cellectis (Euronext Growth Paris)
Ticker: ALCLS
€1.5400
+0.0220 (1.4493%)
- Prev. close
- 1.5180
- Volume
- 20,209
- High
- 1.5500
- Capitalization
- 111.024M
Covering research analysts
Barclays - Gena Wang
Bryan Garnier - Oscar Haffen-Lamm
Citi - Yigal Nochomovitz
Goldman Sachs - Salveen Richter
Jefferies - Kelly Shi
JMP Securities - Silvan Tuerkcan
Jones Trading - Soumit Roy
Kempen - Sebastiaan van der Schoot
Oddo BHF - Martial Descoutures
RW Baird - Jack Allen
Wells Fargo – Yanan Zhu
Cellectis contact information
Arthur Stril, Interim Chief Financial Officer
Citibank ADR contact information
Intermediaries & Investors
US: +1 212 723 5435
UK: +44 207 500 2030
Société Générale Securities Services - Ordinary Shares contact information
Call center in English and French
Monday to Friday from 8:30am to 6pm CEST
+33 (0)2 51 85 67 89